Tags

Type your tag names separated by a space and hit enter

All eyes on a hurdle race for a SARS-CoV-2 vaccine.
Nature. 2020 Oct; 586(7830):501-502.Nat

Links

Publisher Full Text (DOI)

Authors

Gaebler C
No affiliation info available
Nussenzweig MC
No affiliation info available

MeSH

AdolescentAdultB-LymphocytesBetacoronavirusCOVID-19COVID-19 VaccinesClinical Trials as TopicCoronavirus InfectionsHumansMiddle AgedPandemicsPneumonia, ViralSARS-CoV-2T-LymphocytesUnited StatesUnited States Food and Drug AdministrationVaccinationViral VaccinesYoung Adult

Pub Type(s)

News

Language

eng

PubMed ID

33077943

Clinical Trial Links

Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations

Citation

Gaebler, Christian, and Michel C. Nussenzweig. "All Eyes On a Hurdle Race for a SARS-CoV-2 Vaccine." Nature, vol. 586, no. 7830, 2020, pp. 501-502.
Gaebler C, Nussenzweig MC. All eyes on a hurdle race for a SARS-CoV-2 vaccine. Nature. 2020;586(7830):501-502.
Gaebler, C., & Nussenzweig, M. C. (2020). All eyes on a hurdle race for a SARS-CoV-2 vaccine. Nature, 586(7830), 501-502. https://doi.org/10.1038/d41586-020-02926-w
Gaebler C, Nussenzweig MC. All Eyes On a Hurdle Race for a SARS-CoV-2 Vaccine. Nature. 2020;586(7830):501-502. PubMed PMID: 33077943.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - All eyes on a hurdle race for a SARS-CoV-2 vaccine. AU - Gaebler,Christian, AU - Nussenzweig,Michel C, PY - 2020/10/20/entrez PY - 2020/10/21/pubmed PY - 2020/10/24/medline KW - Immunology KW - Medical research KW - SARS-CoV-2 KW - Vaccines SP - 501 EP - 502 JF - Nature JO - Nature VL - 586 IS - 7830 SN - 1476-4687 UR - https://www.unboundmedicine.com/medline/citation/33077943/All_eyes_on_a_hurdle_race_for_a_SARS_CoV_2_vaccine_ DB - PRIME DP - Unbound Medicine ER -